Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Other Non-Current Liabilities (2019 - 2021)

Pliant Therapeutics has reported Other Non-Current Liabilities over the past 3 years, most recently at $756000.0 for Q3 2021.

  • Quarterly Other Non-Current Liabilities rose 96.88% to $756000.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $756000.0 through Sep 2021, up 96.88% year-over-year, with the annual reading at $866000.0 for FY2020, 95.05% up from the prior year.
  • Other Non-Current Liabilities was $756000.0 for Q3 2021 at Pliant Therapeutics, down from $804000.0 in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $951000.0 in Q2 2020 and troughed at $384000.0 in Q3 2020.
  • The 3-year median for Other Non-Current Liabilities is $804000.0 (2021), against an average of $720000.0.
  • The largest YoY upside for Other Non-Current Liabilities was 96.88% in 2021 against a maximum downside of 15.46% in 2021.
  • A 3-year view of Other Non-Current Liabilities shows it stood at $444000.0 in 2019, then skyrocketed by 95.05% to $866000.0 in 2020, then fell by 12.7% to $756000.0 in 2021.
  • Per Business Quant, the three most recent readings for PLRX's Other Non-Current Liabilities are $756000.0 (Q3 2021), $804000.0 (Q2 2021), and $835000.0 (Q1 2021).